0001209191-15-008477.txt : 20150202 0001209191-15-008477.hdr.sgml : 20150202 20150202210711 ACCESSION NUMBER: 0001209191-15-008477 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150129 FILED AS OF DATE: 20150202 DATE AS OF CHANGE: 20150202 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MYLAN INC. CENTRAL INDEX KEY: 0000069499 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 251211621 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 MYLAN BOULEVARD CITY: CANONSBURG STATE: PA ZIP: 15317 BUSINESS PHONE: 724-514-1800 MAIL ADDRESS: STREET 1: 1000 MYLAN BOULEVARD CITY: CANONSBURG STATE: PA ZIP: 15317 FORMER COMPANY: FORMER CONFORMED NAME: MYLAN LABORATORIES INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: FRM CORP DATE OF NAME CHANGE: 19711003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MAROON JOSEPH C MD CENTRAL INDEX KEY: 0001221600 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09114 FILM NUMBER: 15568978 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-01-29 0 0000069499 MYLAN INC. MYL 0001221600 MAROON JOSEPH C MD 1000 MYLAN BLVD CANONSBURG PA 15317 1 0 0 0 Common Stock 2015-01-29 4 M 0 3609 0.00 A 41787 D Restricted Stock Units 0.00 2015-01-29 4 M 0 3609 0.00 D 2015-01-29 Common Stock 3609 0 D Represents acquisition of shares of Mylan common stock upon vesting of RSUs. Each RSU represents the right to receive one share of Mylan common stock. The RSUs were granted on April 11, 2014. The transactions described on this Form 4 are described in the proxy statement filed by Mylan Inc. ("Mylan") on December 24, 2014 and the Form 8-K filed by Mylan on November 5, 2014. In connection with the proposed acquisition (the "Transaction") by a new public company organized in the Netherlands of both Mylan and Abbott Laboratories' non-U.S. developed markets specialty and branded generics business, Mylan's Board of Directors determined, effective November 4, 2014, that the vesting of all unvested stock options, restricted stock units ("RSUs"), and performance restricted stock units granted to directors and executive officers as part of Mylan's ordinary course annual equity compensation program (other than incentive stock options and the options granted in 2014) would be accelerated prior to the Transaction. /s/ Bradley L. Wideman, by power of attorney 2015-02-02